Asset Management Corp’s Bristol-Myers Squibb BMY Stock Holding History

Asset Management Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$496K	Buy	7,156 +23	+0.3%	+$1.62K	0.39%	61
2022 Q4	$513K	Sell	7,133 -1,229	-15%	-$92.7K	0.43%	61
2022 Q3	$594K	Buy	8,362 +18	+0.2%	+$1.31K	0.36%	61
2022 Q2	$642K	Buy	8,344 +18	+0.2%	+$1.37K	0.41%	58
2022 Q1	$608K	Buy	8,326 +693	+9%	+$46.5K	0.3%	74
2021 Q4	$476K	Sell	7,633 -152	-2%	-$8.92K	0.24%	105
2021 Q3	$461K	Buy	7,785 +19	+0.2%	+$1.25K	0.23%	104
2021 Q2	$519K	Sell	7,766 -1,392	-15%	-$90.8K	0.3%	85
2021 Q1	$578	Sell	9,158 -476	-5%	-$29.6K	0.25%	78
2020 Q4	$641K	Buy	9,634 +23	+0.2%	+$1.41K	0.36%	69
2020 Q3	$579K	Buy	9,611 +23	+0.2%	+$1.38K	0.35%	67
2020 Q2	$564K	Sell	9,588 -1,089	-10%	-$65.1K	0.36%	63
2020 Q1	$595K	Buy	10,677 +28	+0.3%	+$1.71K	0.53%	47
2019 Q4	$684K	Buy	+10,649	New	+$610K	0.48%	53

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Asset Management Corp's BMY Position: Q1 2023 in Review

Asset Management Corp increased its Bristol-Myers Squibb (BMY) stake by 0.32% in Q1 2023, buying an estimated $1.62K and bringing the position to 7,156 shares worth $496K. The position accounts for 0.39% of the portfolio, ranked #61.

Asset Management Corp first reported a position in BMY in Q4 2019 and has held it in 14 quarters since. The position peaked at $684K in Q4 2019. 2,541 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Asset Management Corp held 7,156 shares of Bristol-Myers Squibb worth $496K as of Q1 2023.
Asset Management Corp bought 23 Bristol-Myers Squibb shares in Q1 2023, an estimated $1.62K.
Bristol-Myers Squibb made up 0.39% of Asset Management Corp's portfolio in Q1 2023, its #61 holding.
Asset Management Corp first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 14 quarters since.
Asset Management Corp's Bristol-Myers Squibb position peaked at $684K in Q4 2019.
2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Asset Management Corp's 13F filing for Q1 2023, filed 14 Apr 2023.